Meiotic attachment of telomere to nuclear envelope
associated omics data
GO:0070197Ontology (GO BP)GO biological process · ~5 member genes
Q-omics provides the Meiotic attachment of telomere to nuclear envelope (GO:0070197) pathway profile, scoring each patient from the combined activity of its roughly 5 member genes. Pathway activity is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, the pathway is differentially active in 8, with the highest sampling consensus in KICH. Additionally, pathway RNA activity shows 34,728 significant cross-omics associations, again with the highest sampling consensus in KIRC. Together, these results highlight BLCA, KICH, and KIRC as cancer lineages where the pathway shows reproducible signals across outcome, tissue activity, and molecular association analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns. Pathway-against-pathway and pathway-against-mutation comparisons are not available for ontology entities.
Survival associations
This table summarizes Meiotic attachment of telomere to nuclear envelope survival associations by molecular data type. RNA-level pathway activity shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each layer.
This table ranks reproducible pathway activity–survival associations across cancer types. High Meiotic attachment of telomere to nuclear envelope activity shows favorable associations in SCLC, ACC and THYM, but unfavorable associations in BLCA, HNSC and UCS. In the BLCA Kaplan–Meier curve the high-activity group declines faster, consistent with the unfavorable association (log-rank p < 0.001). BLCA ranks highest by sampling consensus for Meiotic attachment of telomere to nuclear envelope.
This table summarizes Meiotic attachment of telomere to nuclear envelope tumor–normal activity differences by data type. RNA-level activity shows significant tumor–normal differences in 8 cancer types, while mass-spec protein activity shows differences in 2. The strongest signals are in KICH for RNA and LUAD for protein.
This table ranks reproducible tumor–normal activity differences for the pathway. A positive fold-change indicates higher activity in tumor tissue. The pathway shows higher tumor activity across KICH, LIHC, CHOL and KIRP and lower tumor activity in BRCA and LUAD. In the KICH box plot, tumor samples show higher pathway activity than matched normal samples (log2 FC = +0.256, t-test p < 0.001).
This table shows molecular features associated with Meiotic attachment of telomere to nuclear envelope pathway activity in patient tissues and cancer cell lines. In patient samples, pathway activity is most strongly linked to RNA and protein features, with the largest associated set in KIRC. In cancer cell lines, RNA-expression features and functional dependencies dominate, with the largest set in BONE.
